PROTOCOL NIDA-CTN-0059


Tobacco, Alcohol, Prescription Medications, and Substance Use/Misuse Brief Screen/Assessment Tool (TAPS Tool)

Robert P. Schwartz, MD
Lead Investigator
Friends Research Institute, Inc.
rschwartz@friendsresearch.org

Li-Tzy Wu, ScD, RN
Lead Investigator
Duke Clinical Research Institute
litzy.wu@duke.edu

Jennifer McNeely, MD
Lead Investigator
New York University

jennifer.mcneely@nyumc.org

This study seeks the validation of a clinically useful brief screening and assessment instrument to identify patients with problematic substance use or a substance use disorder to facilitate brief interventions and referrals to appropriate treatment. Specifically, this study's aims are to 1) develop a two-stage brief screening and assessment instrument to detect unhealthy use of tobacco, alcohol, prescription, and illicit drugs among primary care patients; 2) examine the validity of this 2-state instrument by comparing it to reference standard measures for substance use, problematic use, and substance use disorders; and 3) determine the feasibility of a self-administered 2-stage tool and an interviewer-administered 2-stage tool in US general medical settings.

PRIMARY FINDINGS

Results found that the interviewer- and self-administered versions of the TAPS tool had similar diagnostic characteristics. For identifying problem use (at a cutoff of 1+), the TAPS tool had a sensitivity of 0.93 (95%CI, 0.90 to 0.95) and specificity of 0.87 (CI, 0.85 to 0.89) for tobacco and a sensitivity of 0.74 (CI, 0.70 to 0.78) and specificity of 0.79 (CI, 0.76 to 0.81) for alcohol. For problem use of illicit and prescription drugs, sensitivity ranged from 0.82 (CI, 0.76 to 0.87) for marijuana to 0.63 (CI, 0.47 to 0.78) for sedatives; specificity was 0.93 or higher. For identifying any SUD (at a cutoff of 2+), sensitivity was lower. This study supports the use of the TAPS tool (at a cutoff of 1+) in screening diverse populations of adult primary care patients for problem substance use. Although it may detect tobacco, alcohol, and marijuana use disorders, further refinement is needed before it can be recommended broadly for SUD screening.

Primary Outcomes Article: McNeely J, et al. Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) Tool for Substance Use Screening in Primary Care Patients. Annals of Internal Medicine 2016 (in press). [get article]

RELATED RESOURCES

snowflake

Publications about CTN-0059

ClinicalTrials.gov (NCT02110693)


NODES & CTPs SEARCH LINK
Mid-Atlantic (Lead) search www
Greater New York search www
Southern Consortium search

Supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute.
The materials on this site have neither been created nor reviewed by NIDA.
Updated 1/2017 -- http://ctndisseminationlibrary.org/protocols/ctn0059.htm
info@ctndisseminationlibrary.org